On Oct. 2, the U.S. Food and Drug Administration (FDA) noted that Hospira has recalled one lot of metoclopramide injection and two lost of ondansetron injection because of glass strands found on the inside of the vial walls. Read more.
© 2020 HealthCom Media
All rights reserved. No part of this website or publication may be reproduced, stored, or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the copyright holder